{"filing":{"accession_number":"0001193125-26-234571","cik":"0001285550","ticker":"CLPT","company_name":"ClearPoint Neuro, Inc.","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"clpt-20260520.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526234571/clpt-20260520.htm"},"events":[{"id":9414,"run_id":8254,"accession_number":"0001193125-26-234571","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"ClearPoint Neuro held its Annual Meeting of stockholders and disclosed voting results for four proposals: election of seven directors, ratification of Cherry Bekaert LLP as auditors, advisory approval of executive compensation, and approval of the Seventh Amended and Restated 2013 Incentive Compensation Plan. All proposals were approved by shareholders.","company_name":"ClearPoint Neuro, Inc.","ticker":"CLPT","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":1043,"accession_number":"0001193125-26-234571","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing's primary disclosure is stockholder approval of the \"Seventh Amended and Restated 2013 Incentive Compensation Plan,\" which is a material compensatory arrangement affecting equity grants and performance awards for officers and directors. While the section also includes routine committee appointments and board composition changes, the substantive Item 5.02(e) event centers on the Plan adoption, making exec_compensation the most salient classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:38:44.775874+00:00","company_name":"","ticker":null,"filing_date":""},{"id":1044,"accession_number":"0001193125-26-234571","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is Item 5.07 disclosing the results of an Annual Meeting of stockholders. The filing presents voting results for four proposals: election of seven directors, ratification of auditors (Cherry Bekaert LLP), advisory approval of executive compensation, and approval of the Seventh Amended and Restated 2013 Incentive Compensation Plan. All proposals were approved. This is a standard shareholder vote results disclosure that materially informs investors of governance and compensation decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:38:44.775874+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1043,"accession_number":"0001193125-26-234571","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing's primary disclosure is stockholder approval of the \"Seventh Amended and Restated 2013 Incentive Compensation Plan,\" which is a material compensatory arrangement affecting equity grants and performance awards for officers and directors. While the section also includes routine committee appointments and board composition changes, the substantive Item 5.02(e) event centers on the Plan adoption, making exec_compensation the most salient classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:38:44.775874+00:00","company_name":"ClearPoint Neuro, Inc.","ticker":"CLPT","filing_date":"2026-05-21"},{"id":1044,"accession_number":"0001193125-26-234571","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is Item 5.07 disclosing the results of an Annual Meeting of stockholders. The filing presents voting results for four proposals: election of seven directors, ratification of auditors (Cherry Bekaert LLP), advisory approval of executive compensation, and approval of the Seventh Amended and Restated 2013 Incentive Compensation Plan. All proposals were approved. This is a standard shareholder vote results disclosure that materially informs investors of governance and compensation decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:38:44.775874+00:00","company_name":"ClearPoint Neuro, Inc.","ticker":"CLPT","filing_date":"2026-05-21"}]}